Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | PPARG | P37231 | 1/20 | 0.48 |
| ▸ | PPARA | Q07869 | 1/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.48 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.48 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.48 |
| ▸ | HTR1A | P08908 | 1/20 | 0.48 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.48 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30849683 | 1.00 | RAB9A (0.50) | RAB9AALDH1A1L3MBTL1PPARGPPARA | |
| SCHEMBL14839521 | 0.95 | PPARG (0.54) | RAB9AALDH1A1L3MBTL1PPARGPPARA | |
| SCHEMBL12065148 | 0.91 | RAB9A (0.54) | RAB9AALDH1A1L3MBTL1SLC6A2SLC6A3 | |
| SCHEMBL14839523 | 0.90 | ADRB2 (0.51) | RAB9AALDH1A1L3MBTL1PPARGPPARA | |
| SCHEMBL936318 | 0.90 | PPARG (0.50) | PPARGPPARASLC6A2SLC6A3ADRA1A | |
| SCHEMBL499868 | 0.86 | PPARG (0.54) | L3MBTL1PPARGPPARASLC6A2SLC6A3 | |
| SCHEMBL477470 | 0.86 | PPARG (0.54) | L3MBTL1PPARGPPARASLC6A2SLC6A3 | |
| SCHEMBL5835025 | 0.86 | PPARG (0.54) | L3MBTL1PPARGPPARASLC6A2SLC6A3 | |
| SCHEMBL10021106 | 0.85 | PPARG (0.48) | RAB9AALDH1A1L3MBTL1PPARGPPARA | |
| SCHEMBL3070798 | 0.85 | PPARG (0.50) | RAB9APPARGPPARASLC6A2SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2775996-B1 | USE OF PROPANOL AND PROPENOL DERIVATIVES AS ANTIOXIDANTS | MERCK PATENT GMBH (DE) | 2018-02-28 | — | — | EP | disclosed |
| US-9796696-B2 | Substituted arylcyclopentenes as therapeutic agents | ALLERGAN, INC. (US) | 2017-10-24 | — | — | US | disclosed |
| US-9796696-B2 | Substituted arylcyclopentenes as therapeutic agents | ALLERGAN, INC. (US) | 2017-10-24 | — | — | US | disclosed |
| US-20170057941-A1 | SUBSTITUTED ARYLCYCLOPENTENES AS THERAPEUTIC AGENTS | ALLERGAN, INC. | 2017-03-02 | — | — | US | disclosed |
| US-20170057941-A1 | SUBSTITUTED ARYLCYCLOPENTENES AS THERAPEUTIC AGENTS | ALLERGAN, INC. | 2017-03-02 | — | — | US | disclosed |
| US-9365485-B2 | Substituted arylcyclopentenes as therapeutic agents | ALLERGAN, INC. (US) | 2016-06-14 | — | — | US | disclosed |
| US-20150051295-A1 | USE OF PROPANOL AND PROPENOL DERIVATIVES AS ANTIOXIDANTS | MERCK PATENT GMBH (DE) | 2015-02-19 | — | — | US | disclosed |
| US-20150051295-A1 | USE OF PROPANOL AND PROPENOL DERIVATIVES AS ANTIOXIDANTS | MERCK PATENT GMBH (DE) | 2015-02-19 | — | — | US | disclosed |
| US-20140323510-A1 | SUBSTITUTED ARYLCYCLOPENTENES AS THERAPEUTIC AGENTS | ALLERGAN, INC. (US) | 2014-10-30 | — | — | US | disclosed |
| US-8722726-B2 | Substituted arylcyclopentenes as therapeutic agents | ALLERGAN, INC. (US) | 2014-05-13 | — | — | US | disclosed |
| WO-2013045098-A2 | USE OF PROPANOL AND PROPENOL DERIVATIVES AS ANTIOXIDANTS | MERCK PATENT GMBH (DE) | 2013-04-04 | — | — | WO | disclosed |
| US-8362054-B2 | Therapeutic substituted lactams | ALLERGAN, INC. (US) | 2013-01-29 | — | — | US | disclosed |
| US-20100168189-A1 | THERAPEUTIC SUBSTITUTED LACTAMS | ALLERGAN, INC. | 2010-07-01 | — | — | US | disclosed |
| US-20100137347-A1 | SUBSTITUTED ARYLCYCLOPENTENES AS THERAPEUTIC AGENTS | ALLERGAN, INC. (US) | 2010-06-03 | — | — | US | disclosed |
| US-7713968-B2 | Substituted arylcyclopentenes as therapeutic agents | ALLERGAN, INC. (US) | 2010-05-11 | — | — | US | disclosed |
| US-20090270387-A1 | SUBSTITUTED ARYLCYCLOPENTENES AS THERAPEUTIC AGENTS | ALLERGAN, INC. (US) | 2009-10-29 | — | — | US | disclosed |
| WO-2008091818-A1 | SUBSTITUTED ARYLCYCLOPENTENES AS THERAPEUTIC AGENTS | ALLERGAN, INC. (US) | 2008-07-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140323510-A1 | SUBSTITUTED ARYLCYCLOPENTENES AS THERAPEUTIC AGENTS | ABCB1, THPO, UGT2B7 | RAB9A 1738/4885ALDH1A1 332/4885L3MBTL1 3994/4885 |
| US-20150051295-A1 | USE OF PROPANOL AND PROPENOL DERIVATIVES AS ANTIOXIDANTS | GPX4, EBP, CAT | RAB9A 4513/4885ALDH1A1 134/4885L3MBTL1 3679/4885 |
| US-20170057941-A1 | SUBSTITUTED ARYLCYCLOPENTENES AS THERAPEUTIC AGENTS | ABCB1, THPO, UGT2B7 | RAB9A 1738/4885ALDH1A1 332/4885L3MBTL1 3994/4885 |
| US-20090270387-A1 | SUBSTITUTED ARYLCYCLOPENTENES AS THERAPEUTIC AGENTS | ABCB1, UGT2B7, GBA1 | RAB9A 1394/4885ALDH1A1 299/4885L3MBTL1 3055/4885 |
| US-20100168189-A1 | THERAPEUTIC SUBSTITUTED LACTAMS | PIGO, GARS1, CLPP | RAB9A 1758/4885ALDH1A1 2303/4885L3MBTL1 3603/4885 |
| US-20100137347-A1 | SUBSTITUTED ARYLCYCLOPENTENES AS THERAPEUTIC AGENTS | ABCB1, THPO, UGT2B7 | RAB9A 1852/4885ALDH1A1 160/4885L3MBTL1 4172/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.